Judith & Stewart Colton Center for Autoimmunity

The mission of NYU Langone’s Judith and Stewart Colton Center for Autoimmunity is to elucidate the initiating immunological events and to develop new diagnostics and treatments for autoimmune diseases. To accomplish this goal, the Colton Center has established an extensive research effort among leading physicians and scientists with diverse expertise across the Medical Center and throughout the scientific community. Since its founding in 2013, the Colton Center has become a leading interdisciplinary component of NYU Langone’s strategy and emerging hub in autoimmunity. 

The Judith and Stewart Colton Center for Autoimmunity emphasizes the importance of integrating novel fields of science and technology and collaboration between researchers and clinicians in order to make transformative discoveries designed to identify the environmental trigger and seminal immunological events that characterize the onset of autoimmune diseases.

In 2014, Judith and Stewart Colton made an extraordinary gift to establish the Colton Center for
Autoimmunity at NYU Langone.

The Center initially focused on using the basic science discoveries to develop and test novel strategies in the treatment and diagnosis of its three targeted diseases: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and antiphospholipid syndrome (APS). Synergistic translational research projects now include investigations into psoriatic arthritis, ankylosing spondylitis, and Behcet’s syndrome. Through the funding of new projects, future plans call for the expansion to other diseases such as diabetesinflammatory bowel disease, and multiple sclerosis.

Our Leadership

The center is led by Steven Abramson, MD, the Frederick H. King Professor of Internal Medicine and chair of the Department of Medicine. He also serves as senior vice president and vice dean for education, faculty, and academic affairs. Dr. Abramson is internationally recognized for basic science and clinical research in the field of inflammation and autoimmunity, and has published more than 300 papers in peer reviewed journals.  In recent NIH-funded studies in collaboration with members of the Colton Center, the Abramson Lab has examined the role of the intestinal microbiome in the development of rheumatoid and psoriatic arthritis.